Citadel Advisors’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,346
| Closed | -$1.52M | – | 6609 |
|
|
2025
Q1 | $1.52M | Buy |
123,346
+84,739
| +219% | +$1.04M | ﹤0.01% | 2852 |
|
|
2024
Q4 | $432K | Buy |
38,607
+22,126
| +134% | +$248K | ﹤0.01% | 4153 |
|
|
2024
Q3 | $115K | Sell |
16,481
-20,631
| -56% | -$144K | ﹤0.01% | 4868 |
|
|
2024
Q2 | $281K | Buy |
37,112
+28,962
| +355% | +$219K | ﹤0.01% | 4359 |
|
|
2024
Q1 | $108K | Sell |
8,150
-15,905
| -66% | -$210K | ﹤0.01% | 5049 |
|
|
2023
Q4 | $248K | Buy |
+24,055
| New | +$248K | ﹤0.01% | 4410 |
|
|
2022
Q3 | – | Sell |
-21,692
| Closed | -$108K | – | 6427 |
|
|
2022
Q2 | $108K | Buy |
+21,692
| New | +$108K | ﹤0.01% | 5259 |
|
|
2022
Q1 | – | Sell |
-10,009
| Closed | -$101K | – | 6865 |
|
|
2021
Q4 | $101K | Sell |
10,009
-15,813
| -61% | -$160K | ﹤0.01% | 5903 |
|
|
2021
Q3 | $410K | Buy |
+25,822
| New | +$410K | ﹤0.01% | 4732 |
|